Ashley A. McCook‐Veal

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

Nabil F. Saba, Conor Steuer, Asari Ekpenyong et al. · Nature Medicine · 2023 · 76 citations · Full text

Medicine, Oncology, Pharmacology +12

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Rajesh M. Valanparambil, Jennifer W. Carlisle, Susanne L. Linderman et al. · Journal of Clinical Oncology · 2022 · 43 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma

Nabil F. Saba, Stuart J. Wong, Tahseen H. Nasti et al. · JAMA Oncology · 2024 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +17

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial

Maggie J. Phillips, Olatunji B. Alese, Natalie K. Horvat et al. · OncoImmunology · 2025 · 13 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study

Pamela B. Allen, Ashley A. McCook‐Veal, Jeffrey M. Switchenko et al. · Cancer · 2022 · 12 citations · Full text

Medicine, Oncology, Pathology +17